(Q24301858)

cytochrome P450 family 1 subfamily A member 2

1 reference

cytochrome P450 family 2 subfamily D member 6

1 reference

heterocycle metabolic process

1 reference

5

David A Flockhart

0 references

Zeruesenay Desta

6

object named as

Zeruesenay Desta

0 references

author name string

Bryan A Ward

1

0 references

Alan Morocho

2

0 references

Abdullah Kandil

3

0 references

Raymond E Galinsky

British Journal of Clinical Pharmacology

4

0 references

language of work or name

English

0 references

publication date

September 2004

0 references

published in

0 references

volume

58

0 references

issue

3

0 references

page(s)

277-87

0 references

cites work

In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Lessons from the CYP3A4 promoter

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Human liver aldehyde oxidase: inhibition by 239 drugs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

QT Prolongation and Fatal Arrhythmias: A Review of Clinical Implications and Effects of Drugs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Domperidone: a peripherally acting dopamine2-receptor antagonist

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

In vitro and in vivo drug interactions involving human CYP3A.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Cardiac arrest after treatment with intravenous domperidone.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Q-T interval prolongation and ventricular fibrillation with i.v. domperidone

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity

30 May 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02156.X

Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02156.X

Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02156.X

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02156.X

Distribution of domperidone into the rat brain is increased by brain ischaemia or treatment with the P-glycoprotein inhibitor verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02156.X

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884565

On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration

29 November 2018

1 reference

12 December 2020

Sudden death in cancer patient on high-dose domperidone

1 reference

12 December 2020

TWO SUDDEN DEATHS DURING PROPHYLACTIC ANTIEMETIC TREATMENT WITH HIGH DOSES OF DOMPERIDONE AND METHYLPREDNISOLONE

1 reference

12 December 2020

Cardiac arrest after treatment with intravenous domperidone

1 reference

12 December 2020

Cardiotoxicity of intravenous domperidone

1 reference

12 December 2020

Cardiotoxicity of intravenous, domperidone

1 reference

12 December 2020

Cardiotoxicity of domperidone

1 reference

12 December 2020

Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone

1 reference

12 December 2020

Mechanism of the cardiotoxic actions of terfenadine

1 reference

12 December 2020

Identification and characterization of human cytochrome P450 isoforms interacting with pimozide

1 reference

12 December 2020

Domperidone. A review of its use in diabetic gastropathy

1 reference

12 December 2020

Molecular and physical mechanisms of first-pass extraction

1 reference

12 December 2020

Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders

1 reference

12 December 2020